Continuing review of an approved and ongoing study posing more than minimal risk that was initially approved by a convened IRB:

A. Must be conducted by a convened IRB.

B. Is not required unless additional risks have been identified.

C. Is limited to review of unanticipated problems.

D. Must occur within 12 months of the approval date.

Question

Guest

Social Studies

12 June, 06:03

Continuing review of an approved and ongoing study posing more than minimal risk that was initially approved by a convened IRB:

A. Must be conducted by a convened IRB.

B. Is not required unless additional risks have been identified.

C. Is limited to review of unanticipated problems.

D. Must occur within 12 months of the approval date.

+4

Answers (1)

Know the Answer?

Rodney Dickerson · Answer 1

Must occur within 12 months of the approval date

Explanation:

A continuing review is usually mandated by the federal government and entails a re-evaluation of a study that is approved and this is done at least once every year. In the same manner, approvals from IRB lasts for a period of 12 months from the day the first approval was given. The IRB will always send renewal notice 60 days and 30 days before the expiration date of the research study.